CCL17 has also been shown to be involved in Th2-mediated cystic fibrosis (Tiringer et al., 2013), peritoneal fibrosis (Terri et al., 2021), and the granuloma formation of sarcoidosis (Nguyen et al., 2018). Here, CCL17 is linked to cystic fibrosis.